Comparison of the effects of high dose testosterone and 19-nortestosterone to a replacement dose of testosterone on strength and body composition in normal men

https://doi.org/10.1016/0960-0760(91)90283-BGet rights and content

Abstract

We examined the extent to which supraphysiological doses of androgen can modify body composition and strength in normally virilized men. In doubly blind tests, 30 healthy young men received testosterone enanthate (TE) or 19-nortestosterone decanoate (ND), at 100 mg/wk or 300 mg/wk for 6 weeks. The TE-100 mg/wk group served as replacement dose comparison, maintaining pretreatment serum testosterone levels, while keeping all subjects blinded to treatment, particularly through reduction in testicular volumes. Isokinetic strength measurements were made for the biceps brachii and quadriceps femoris muscle groups before treatment and 2–3 days after the 6th injection. Small improvements were noted in all groups but the changes were highly variable; a trend to greater and more consistent strength gain occured in the TE-300 mg/wk group. There was no change in weight for TE-100 mg/wk but an average gain of 3 kg in each of the other groups. No changes in 4 skinfold thickness or in estimated percent body fat were observed. Of 15 circumferences, significant increases were observed only for men receiving TE-300 mg/wk (shoulders) and ND-300 mg/wk (shoulders and chest). The data suggest that high dose androgens increase body mass and may increase strength in normal men but, except for a consistent weight gain with greater than replacement doses, the detectable changes were highly variable and relatively small, especially in comparison to the significant alterations which were observed for other markers of androgen action.

References (30)

  • N. Wade

    Anabolic steroids: doctors denounce them, but athletes aren't listening

    Science

    (1972)
  • J.G. Hershberger et al.

    Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method

  • K.E. Friedl

    Reappraisal of the health risks associated with the use of high doses of oral and injectable androgenic steroids

  • K.E. Friedl et al.

    Self-treatment of gynecomastia in body-builders who use anabolic steroids

    Phys. Sportsmed.

    (1989)
  • H.P. Wijnand et al.

    Pharmacokinetic parameters of nandrolone (19-nortestosterone) after intramuscular administration of nandrolone decanoate (Deca-Durabolin) to healthy volunteers

    Acta Endocr.

    (1985)
  • Cited by (57)

    • Androgenic Steroids Use and Abuse: Past, Present, and Future

      2022, Urologic Clinics of North America
      Citation Excerpt :

      There are also numerous observational reports that describe uncharacteristically aggressive or violent behaviors in previously normal individuals5,49 who are using AASs. There have also been studies of supraphysiologic androgen exposure in healthy men using 300 mg of testosterone enanthate per week that demonstrated no adverse psychiatric effects50–53 but this dosage is not comparable with those used by many chronic AAS abusers (500–1000 mg or greater per week). Placebo-controlled studies of the effects of 500 mg per week of testosterone3,54–57 showed that 4.6% of men had hypomanic or manic symptoms compared with none on placebo.

    • Anabolic-Androgenic Steroids

      2013, Disease-a-Month
      Citation Excerpt :

      Generally, the dose of AASs is lower in women than men. Data from human test participants indicate that AAS produce a dose-dependent and sex-dependent increase in lean body mass and strength, but the changes are highly variable and relatively small without an accompanying conditioning and strength program.37 The administration of AAS to men participating in weight training consistently produces increased strength when compared with controls (i.e., weight training alone).28

    • Illicit anabolic-androgenic steroid use

      2010, Hormones and Behavior
    View all citing articles on Scopus

    The views, opinions, and findings in this report are those of the authors and should not be constructed as an official Department of the Army position, policy or decision.

    View full text